Figure 5
Figure 5. The IKK-NF-κB pathway is activated in LRP-1-deficient cells. (A) PEA-10 and MEF-2 cells were treated with TNF-α (50 ng/mL) or with vehicle for 10 minutes. Equal amounts of cell extract were subjected to immunoblot analysis for phosphorylated IKK, total IKK, phosphorylated IκB, total IκB, phosphorylated NF-κB, total NF-κB, and tubulin. (B) PEA-10 and MEF-2 cells were transfected with pNF-κB-Luc to measure NF-κB activity. Cells were treated with TNF-α (50 ng/mL) or vehicle. Luciferase activity was measured 6 hours later. Error bars represent SD. (C) CL-16 and shLRP-1 cells were treated with TNF-α (50 ng/mL) or with vehicle for 10 minutes. Equal amounts of cell extract were subjected to immunoblot analysis for total IKK, phosphorylated IκB, and total IκB.

The IKK-NF-κB pathway is activated in LRP-1-deficient cells. (A) PEA-10 and MEF-2 cells were treated with TNF-α (50 ng/mL) or with vehicle for 10 minutes. Equal amounts of cell extract were subjected to immunoblot analysis for phosphorylated IKK, total IKK, phosphorylated IκB, total IκB, phosphorylated NF-κB, total NF-κB, and tubulin. (B) PEA-10 and MEF-2 cells were transfected with pNF-κB-Luc to measure NF-κB activity. Cells were treated with TNF-α (50 ng/mL) or vehicle. Luciferase activity was measured 6 hours later. Error bars represent SD. (C) CL-16 and shLRP-1 cells were treated with TNF-α (50 ng/mL) or with vehicle for 10 minutes. Equal amounts of cell extract were subjected to immunoblot analysis for total IKK, phosphorylated IκB, and total IκB.

Close Modal

or Create an Account

Close Modal
Close Modal